Authors

• Preston Ngo (ORCID: https://orcid.org/0000-0001-5453-0734)
• Jason H. Karnes
• Kiana L. Martinez (ORCID: https://orcid.org/0000-0001-9209-5139)
• Tam C. Tran
• Matthew J. Huentelman (ORCID: https://orcid.org/0000-0001-7390-9918)
• A. Vicenti
• Eric M. Reiman (ORCID: https://orcid.org/0000-0002-0705-3696)
• Valentina Ghisays (ORCID: https://orcid.org/0000-0002-8434-9407)
• Joshua C. Denny (ORCID: https://orcid.org/0000-0002-3049-7332)
• Travis J. Wheeler (ORCID: https://orcid.org/0000-0003-2004-1785)
• Ehsan Khajouei (ORCID: https://orcid.org/0000-0003-4565-7770)
• Ignazio Stefano Piras (ORCID: https://orcid.org/0000-0003-4024-3368)
• Marcus Naymik

Institutions

• Translational Genomics Research Institute (US)
• National Institutes of Health (US)
• University of Arizona (US)
• National Human Genome Research Institute (US)
• Banner Alzheimer’s Institute
• Vanderbilt University Medical Center (US)

Publication Details

Journal

EBioMedicine

Published

2025-05-30

DOI

https://doi.org/10.1016/j.ebiom.2025.105768

Citations

7

Primary Topic

Diabetes, Cardiovascular Risks, and Lipoproteins

Type

article

Field-Weighted Citation Impact

9.06

Funders

• National Institutes of Health
• National Heart, Lung, and Blood Institute
• National Human Genome Research Institute
• NIH Office of the Director